Fortrea Holdings, Inc. engages in the provision of clinical development and commercialization services. It operates under the Clinical Services and Enabling Services Segments. The Clinical Services segment provides services across the clinical pharmacology, clinical development, and other clinical service spectrum utilizing enabling services and technology through multiple delivery models. The Enabling Services segment provides technology solutions directly to customers that streamline complex randomization and optimize the trial drug supply process, while minimizing operational costs and supporting timely and accurate patient dosing. The company was founded on January 31, 2023 and is headquartered in Durham, NC.
Current Value
$18.701 Year Return
Current Value
$18.701 Year Return
Market Cap
$1.68B
P/E Ratio
-5.95
1Y Stock Return
-42.77%
1Y Revenue Growth
0.00%
Dividend Yield
0.00%
Price to Book
1.1
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CRL | 51.49% | $9.52B | -3.20% | 0.00% |
ALRM | 49.88% | $2.95B | +3.34% | 0.00% |
TASK | 48.98% | $1.27B | +16.72% | 0.00% |
IQV | 45.90% | $34.73B | -7.77% | 0.00% |
AXL | 44.94% | $723.12M | -13.74% | 0.00% |
DOCS | 43.81% | $9.62B | +114.35% | 0.00% |
MEDP | 42.76% | $9.79B | +14.00% | 0.00% |
PBPB | 41.58% | $293.68M | +4.36% | 0.00% |
AAON | 40.90% | $10.66B | +106.55% | 0.24% |
IMXI | 40.47% | $651.21M | -1.55% | 0.00% |
CLDT | 39.58% | $425.53M | -12.03% | 3.24% |
RC | 39.15% | $1.22B | -27.41% | 15.95% |
G | 39.13% | $7.83B | +31.86% | 1.34% |
AXON | 39.00% | $46.53B | +167.14% | 0.00% |
WGO | 38.80% | $1.67B | -12.54% | 2.20% |
DENN | 38.26% | $321.32M | -35.73% | 0.00% |
KFRC | 38.24% | $1.10B | -8.71% | 0.66% |
PLYA | 37.81% | $1.16B | +23.51% | 0.00% |
GHM | 37.69% | $464.78M | +132.21% | 0.00% |
IRTC | 37.38% | $2.36B | -9.35% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
QNRX | <0.01% | $3.20M | -85.07% | 0.00% |
NABL | -0.09% | $1.88B | -14.67% | 0.00% |
FENG | 0.16% | $13.37M | +96.77% | 0.00% |
MASI | -0.32% | $8.75B | +73.22% | 0.00% |
CAPR | -0.34% | $839.37M | +532.19% | 0.00% |
CYCN | -0.37% | $4.77M | -16.19% | 0.00% |
SRRK | -0.38% | $2.61B | +134.91% | 0.00% |
KSPI | -0.38% | $20.86B | +18.06% | 3.37% |
JNPR | -0.48% | $11.61B | +30.55% | 2.49% |
TCTM | 0.57% | $8.10M | -42.99% | 0.00% |
OBDE | -0.57% | $1.82B | -2.27% | 4.76% |
MIST | 0.60% | $92.79M | -32.56% | 0.00% |
EDU | 0.75% | $9.06B | -22.20% | 0.00% |
FTNT | -0.90% | $69.59B | +72.67% | 0.00% |
API | 0.93% | $299.01M | +33.12% | 0.00% |
CORZ | 1.04% | $4.60B | +3,201.26% | 0.00% |
LMT | 1.04% | $126.40B | +18.99% | 2.36% |
LX | -1.08% | $446.80M | +57.07% | 4.21% |
LFWD | -1.11% | $16.21M | -63.99% | 0.00% |
CRDF | -1.16% | $133.97M | +127.83% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PRPH | -31.50% | $18.14M | -82.61% | 0.00% |
RVNC | -21.72% | $394.43M | -47.99% | 0.00% |
CYD | -17.40% | $364.46M | -2.94% | 4.26% |
PSEC | -16.84% | - | - | 15.48% |
HUSA | -16.83% | $16.69M | -11.56% | 0.00% |
PDD | -16.43% | $163.43B | +0.29% | 0.00% |
VSTA | -13.08% | $204.94M | -39.33% | 0.00% |
EVH | -12.91% | $1.39B | -58.46% | 0.00% |
DOGZ | -12.89% | $614.77M | +1,372.26% | 0.00% |
WHF | -11.01% | - | - | 14.53% |
TECX | -10.17% | $602.80M | +170.24% | 0.00% |
FIGS | -9.49% | $840.56M | -25.56% | 0.00% |
PINS | -9.22% | $20.07B | -5.95% | 0.00% |
AKAM | -9.07% | $13.12B | -22.78% | 0.00% |
NVAX | -8.50% | $1.28B | +49.53% | 0.00% |
AMN | -7.96% | $953.75M | -62.61% | 0.00% |
KT | -7.87% | $7.55B | +19.08% | 6.85% |
CIG.C | -7.68% | $2.48B | -3.55% | 0.00% |
PTMN | -7.42% | - | - | 16.06% |
BCAN | -6.96% | $72.87M | -99.75% | 0.00% |
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
SMOT | 47.34% | $374.04M | 0.49% |
IVOG | 47.03% | $1.12B | 0.15% |
GRPM | 46.52% | $582.50M | 0.35% |
VXF | 46.13% | $21.54B | 0.06% |
EES | 45.99% | $668.71M | 0.38% |
VIOV | 45.81% | $1.44B | 0.15% |
SLYV | 45.76% | $4.16B | 0.15% |
TMSL | 45.72% | $288.12M | 0.55% |
RWJ | 45.71% | $1.75B | 0.39% |
IJS | 45.70% | $7.37B | 0.18% |
PRFZ | 45.68% | $2.65B | 0.39% |
VBR | 45.64% | $32.03B | 0.07% |
EZM | 45.55% | $823.84M | 0.38% |
SCHM | 45.52% | $11.59B | 0.04% |
VTWO | 45.49% | $12.38B | 0.1% |
IWM | 45.48% | $75.73B | 0.19% |
DSTL | 45.44% | $2.02B | 0.39% |
FNX | 44.79% | $1.29B | 0.6% |
FMDE | 44.61% | $2.02B | 0.23% |
SMMV | 44.27% | $321.07M | 0.2% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
SOYB | -0.24% | $27.32M | 0.22% |
ULST | -0.36% | $535.47M | 0.2% |
HDRO | -1.28% | $164.26M | 0.3% |
KRBN | 1.30% | $242.47M | 0.85% |
BSCO | 1.35% | $2.35B | 0.1% |
JBBB | 1.50% | $1.26B | 0.49% |
HIGH | -1.51% | $302.78M | 0.51% |
CLOI | 1.51% | $715.40M | 0.4% |
SHV | 1.58% | $18.13B | 0.15% |
UNG | -1.99% | $908.80M | 1.06% |
BOXX | 2.00% | $4.43B | 0.1949% |
TBIL | 2.20% | $4.38B | 0.15% |
GBIL | 2.55% | $5.60B | 0.12% |
XONE | 2.76% | $548.88M | 0.03% |
YEAR | 3.23% | $1.13B | 0.25% |
IBHD | 3.47% | $327.80M | 0.35% |
IVOL | 3.79% | $548.70M | 1.02% |
KCCA | 3.95% | $220.51M | 0.87% |
KMLM | -4.24% | $353.87M | 0.9% |
AGZD | 4.32% | $142.76M | 0.23% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -26.07% | $388.04M | 1.43% |
VIXY | -22.68% | $195.31M | 0.85% |
TPMN | -17.80% | $40.60M | 0.65% |
TAIL | -15.63% | $67.98M | 0.59% |
UUP | -14.69% | $309.25M | 0.77% |
DBE | -13.69% | $50.13M | 0.77% |
PDBC | -13.30% | $4.40B | 0.59% |
DBO | -13.26% | $217.57M | 0.77% |
COMT | -12.99% | $829.06M | 0.48% |
DBC | -12.71% | $1.39B | 0.87% |
GSG | -12.31% | $914.42M | 0.75% |
BCI | -11.77% | $1.20B | 0.26% |
USDU | -11.56% | $201.97M | 0.5% |
CMDY | -10.93% | $279.14M | 0.28% |
BCD | -10.86% | $245.02M | 0.3% |
WEAT | -10.42% | $120.27M | 0.28% |
CTA | -10.13% | $350.27M | 0.78% |
JUCY | -9.98% | $324.29M | 0.6% |
CORN | -9.76% | $61.12M | 0.2% |
EQLS | -9.36% | $76.08M | 1% |
SeekingAlpha
Tracking Seth Klarman's Baupost Group Holdings - Q3 2024 Update
Yahoo
Shareholders will be ecstatic, with their stake up 35% over the past week following Fortrea Holdings Inc. 's...
Yahoo
Baird raised the firm’s price target on Fortrea (FTRE) to $30 from $28 and keeps an Outperform rating on the shares. The firm expects superlative EPS growth and recovery, particularly in 2H25 and believes they’ll get through TSA and spin transitions in early 2025, with revenue growth resumption, cost leverage, and better interest expense additive. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on
Yahoo
Fortrea Holdings ( NASDAQ:FTRE ) Third Quarter 2024 Results Key Financial Results Revenue: US$674.9m (down 13% from 3Q...
Finnhub
NEW YORK, Nov. 10, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Fortrea Holdings Inc. . Such investors are advised to contact Danielle Peyton at...
Yahoo
Despite revenue decline, Fortrea Holdings Inc (FTRE) showcases strong demand with a solid book-to-bill ratio and promising growth prospects.